Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Hvidberg

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|July 1, 1990
Why do we need pharmacokinetic studies?E F Hvidberg
BMJ (Clinical Research Ed.)|September 2, 1989
Good clinical practice: a way to better drugsE F Hvidberg
Drugs|February 1, 1993
Regulatory implications of good clinical practice. Towards harmonisationE F Hvidberg
Arzneimittel-Forschung|January 1, 1976
Proceedings: Plasma levels, anti-epileptics and anti-depressantsE F Hvidberg
Clinical Pharmacology and Therapeutics|May 1, 1976
Drug evaluation, educational system, and clinical pharmacologic training in a small countryE F Hvidberg
Ugeskrift for Laeger|February 7, 1994
[Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"]E F Hvidberg
Progress in Clinical and Biological Research|January 1, 1986
Ethnic differences in phenytoin kineticsE F Hvidberg
Scandinavian Journal of Primary Health Care|May 1, 1986
Drug epidemiology--further research refinementsE F Hvidberg
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Active metabolites in antiepileptic therapy. Reflections on a pharmacological jokerE F Hvidberg
European Journal of Clinical Pharmacology|April 1, 1980
Monitoring drug plasma levels in clinical practice? A procedure for evaluation is neededE F Hvidberg
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|July 1, 1990
Why do we need pharmacokinetic studies?E F Hvidberg
BMJ (Clinical Research Ed.)|September 2, 1989
Good clinical practice: a way to better drugsE F Hvidberg
Drugs|February 1, 1993
Regulatory implications of good clinical practice. Towards harmonisationE F Hvidberg
Arzneimittel-Forschung|January 1, 1976
Proceedings: Plasma levels, anti-epileptics and anti-depressantsE F Hvidberg
Clinical Pharmacology and Therapeutics|May 1, 1976
Drug evaluation, educational system, and clinical pharmacologic training in a small countryE F Hvidberg
Ugeskrift for Laeger|February 7, 1994
[Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"]E F Hvidberg
Progress in Clinical and Biological Research|January 1, 1986
Ethnic differences in phenytoin kineticsE F Hvidberg
Scandinavian Journal of Primary Health Care|May 1, 1986
Drug epidemiology--further research refinementsE F Hvidberg
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Active metabolites in antiepileptic therapy. Reflections on a pharmacological jokerE F Hvidberg
European Journal of Clinical Pharmacology|April 1, 1980
Monitoring drug plasma levels in clinical practice? A procedure for evaluation is neededE F Hvidberg
Pageof 8